| Secondary |
| Product Used For Unknown Indication |
42.4% |
| Drug Use For Unknown Indication |
27.1% |
| Type 2 Diabetes Mellitus |
5.2% |
| Depression |
4.4% |
| Hypertension |
4.4% |
| Constipation |
1.8% |
| Acute Lymphocytic Leukaemia |
1.6% |
| Back Pain |
1.6% |
| Hepatic Encephalopathy |
1.6% |
| Epilepsy |
1.4% |
| Osteoporosis |
1.4% |
| Ill-defined Disorder |
1.2% |
| Sciatica |
1.2% |
| Acute Promyelocytic Leukaemia |
0.8% |
| Musculoskeletal Pain |
0.8% |
| Rheumatoid Arthritis |
0.8% |
| Abdominal Pain |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Pain |
0.6% |
| Bone Pain |
0.4% |
|
| Tricuspid Valve Disease |
8.8% |
| Hypertriglyceridaemia |
7.4% |
| Myositis |
7.4% |
| Oedema Peripheral |
7.4% |
| Thrombocytopenia |
7.4% |
| Agranulocytosis |
5.9% |
| Pleural Effusion |
5.9% |
| Pulmonary Arterial Hypertension |
5.9% |
| Somnolence |
5.9% |
| Aortic Valve Incompetence |
4.4% |
| Pulmonary Embolism |
4.4% |
| Pulmonary Fibrosis |
4.4% |
| Renal Failure Acute |
4.4% |
| Atrial Flutter |
2.9% |
| Confusional State |
2.9% |
| Cytolytic Hepatitis |
2.9% |
| Malaise |
2.9% |
| Neutropenia |
2.9% |
| Rash |
2.9% |
| Renal Failure Chronic |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.7% |
| Product Used For Unknown Indication |
16.6% |
| Constipation |
8.3% |
| Prophylaxis |
7.0% |
| Hypertension |
6.4% |
| Surgery |
6.3% |
| Pain |
6.0% |
| Dyspepsia |
4.3% |
| Abdominal Pain |
3.4% |
| Medical Diet |
2.9% |
| Hepatic Neoplasm Malignant |
2.4% |
| Rhinitis Allergic |
2.3% |
| Multiple Myeloma |
2.3% |
| Cystitis |
2.2% |
| Depression |
2.2% |
| Non-small Cell Lung Cancer |
2.1% |
| Epilepsy |
1.8% |
| Oesophagitis |
1.7% |
| Mucosal Inflammation |
1.6% |
| Diabetes Mellitus |
1.6% |
|
| Thrombocytopenia |
10.8% |
| Vomiting |
9.4% |
| Rectal Ulcer |
6.7% |
| Weight Decreased |
6.4% |
| Hepatic Encephalopathy |
5.7% |
| Renal Failure |
5.4% |
| Neutropenia |
5.1% |
| Hyponatraemia |
4.7% |
| Pyrexia |
4.7% |
| Septic Shock |
4.7% |
| Renal Failure Acute |
4.4% |
| Somnolence |
4.4% |
| Drug Interaction |
4.0% |
| Overdose |
3.7% |
| Blood Bilirubin Increased |
3.4% |
| Febrile Bone Marrow Aplasia |
3.4% |
| Pneumonia |
3.4% |
| Pulmonary Embolism |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Rash |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
79.2% |
| Acute Promyelocytic Leukaemia |
20.8% |
|
| Drug Interaction |
71.4% |
| International Normalised Ratio Increased |
14.3% |
| Myositis |
14.3% |
|
